TESHIA JONES: Open Payments
NPI 1346522281 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,503 in 126 payments from 17 companies in 2025. Trend: 2023 $2,963 · 2024 $1,795 · 2025 $2,503
Food & beverage: $2,503
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 32 | $604 |
| Neurocrine BioSciences, Inc. | 12 | $287 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $247 |
| ABBVIE INC. | 11 | $241 |
| Otsuka America Pharmaceutical, Inc. | 14 | $191 |
| Lundbeck LLC | 7 | $185 |
| Teva Pharmaceuticals USA, Inc. | 10 | $141 |
| Vanda Pharmaceuticals Inc. | 6 | $125 |
| Bausch Health US, LLC | 6 | $118 |
| Axsome Therapeutics, Inc. | 5 | $99 |
Products named: REXULTI, ARISTADA, INGREZZA, CAPLYTA, VRAYLAR, VIVITROL, LYBALVI, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
